DEVA HOLDİNG A.Ş. Logo

DEVA HOLDİNG A.Ş.

Develops, produces, and markets human medicines, APIs, and veterinary drugs globally.

DEVA | IS

Overview

Corporate Details

ISIN(s):
TRADEVAW91E2
LEI:
959800K5PD9GB1EHW234
Country:
Spain
Address:
AVDA CANTABRIA S / N, 28660 Boadilla del Monte

Description

Established in 1958, DEVA Holding A.Ş. is a pharmaceutical company focused on the development, production, and marketing of medicinal products for human use and active pharmaceutical ingredients (APIs). The company also produces veterinary drugs. DEVA Holding maintains a diverse product portfolio, which includes antineoplastic and immunomodulating agents, and makes its products available on a global scale. Its international business operations are managed through various models, including distributorships, out-licensing, and direct supply agreements.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2021-02-02 10:03
TRSDEVA42219 ISIN kodlu tahvilin 3.kupon ödemesi ve 4.kupon faiz oranının belir…
English 20.4 KB
2021-02-02 10:03
TRSDEVA52119 ISIN kodlu tahvilin 11.kupon ödemesi ve 12.kupon faiz oranının bel…
English 25.9 KB
2020-12-12 09:06
Company General Info Form
Turkish 7.8 KB
2020-12-12 09:06
Bağlı ortaklık sermayesi.
Turkish 17.6 KB
2020-11-06 16:14
Sorumluluk Beyanı
Turkish 24.0 KB
2020-11-06 16:14
30.09.2020 faaliyet raporu.
Turkish 1.9 MB
2020-11-06 16:14
30.09.2020 faaliyet raporu.
English 10.9 KB
2020-11-06 16:13
Financial Report
Turkish 1.1 MB
2020-11-06 16:13
Financial Report
English 2.5 MB
2020-11-03 10:18
TRSDEVA42219 ISIN kodlu tahvilin 2.kupon ödemesi ve 3.kupon faiz oranının belir…
English 20.3 KB
2020-11-03 10:18
TRSDEVA52119 ISIN kodlu tahvilin 10.kupon ödemesi ve 11.kupon faiz oranının bel…
English 25.8 KB
2020-09-22 18:30
Company General Info Form
Turkish 13.9 KB
2020-08-14 18:06
Sorumluluk beyanı
Turkish 26.0 KB
2020-08-14 18:05
Financial Report
Turkish 1.4 MB
2020-08-14 18:05
Financial Report
English 2.5 MB

Automate Your Workflow. Get a real-time feed of all DEVA HOLDİNG A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DEVA HOLDİNG A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DEVA HOLDİNG A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.